newsfilter
← Latest News
GlobeNewswire·

Genelux Corporation Reports Second Quarter 2024 Financial Results and Provides General Business Updates

WESTLAKE VILLAGE, Calif., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ:GNLX), a late clinical-stage immuno-oncology company, today announced financial results for the second quarter of 2024 and